Articles in Biotech

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
Achillion Pharma (NASDAQ:ACHN) expects to receive net proceeds of approximately $50 million from a private placement that includes …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
Biogen Idec (NASDAQ:BIIB) announced yesterday that it made an equity investment and deal that included potential license payments …

I have been using the wikinvest.com portfolio tracker software for the past few months and have found it to be a useful tool for tracking my real money Ameritrade portfolio (see left column of …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
DepoMed (NASDAQ:DEPO) announced that it has reached a Special Protocol Assessment (SPA) agreement with the FDA for the …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
Vertex Pharma (NASDAQ:VRTX) reported Phase 3 ILLUMINATE study results for telaprevir (VX-950 or TVR) that included SVR / …

Below are some stocks trading at $1 per share or less with pending binary events in the form of expected FDA decisions or clinical trial results that are expected to have a major percentage …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
Amarin Corp. (NASDAQ:AMRN) has a conference call scheduled for Tuesday 10-August at 11am (ET) and plans to provide …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
Penwest Pharma (NASDAQ:PPCO) expects to report top-line results for a pair of ongoing Phase 2a studies by year-end …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
Affymax (NASDAQ:AFFY) and partner Takeda Pharma (OTC:TKPHY) reported that further analysis is ongoing for the previously reported pivotal …

Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news…
AtriCure (NASDAQ:ATRC) expects to file the final clinical module with the FDA for a Pre-Market Approval (PMA) submission …